Evaluation of the Protective Effect of Silymarin Phytosome Nanoparticles on Ethanol-Induced Diseas e Toxicity in Rats

Authors

  • Arezoo Gohari Mahmoudabad - Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. - Department of Medical Nanotechnology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. orcid https://orcid.org/0000-0001-6801-7157
  • Fatemeh Gheybi - Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. orcid https://orcid.org/0000-0001-9209-251X
  • Mohsen Mehrabi - Department of Medical Nanotechnology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. orcid https://orcid.org/0000-0002-9891-4964
  • Alireza Masoudi - Department of Pharmacology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. orcid https://orcid.org/0000-0002-5598-9384
  • Zeinab Mobasher - Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Hamid Vahedi - Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran. - Department of Gastroenterology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. orcid https://orcid.org/0000-0002-3482-3457
  • Anneh Mohammad Gharravi - Department of Nursing, Gonbad Kavous School of Nursing, Golestan University of Medical Sciences, Gonbad Kavous, Iran. - Department of Anatomy, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. orcid https://orcid.org/0000-0001-5113-5982
  • Fatemeh Sadat Bitaraf - Department of Medical Biotechnology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Seyed Mahdi Rezayat Sorkhabadi - Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

DOI:

https://doi.org/10.22100/jkh.v21i1.3616

Keywords:

Phytosome, Silymarin, Hepatotoxicity, Ethanol

Abstract

Introduction: Silymarin, a plant-derived compound with well-established hepatoprotective properties, has demonstrated significant therapeutic potential in the prevention and treatment of various liver diseases, including alcoholic liver disease (ALD). However, its clinical application is limited by low bioavailability and poor absorption, resulting in reduced therapeutic efficacy. In the present study, silymarin phytosome nanoparticles were prepared and evaluated to enhance bioavailability and improve its hepatoprotective effects.

Methods: Silymarin phytosome nanoparticles were synthesized using the thin-film hydration method. Physicochemical properties, including particle size, zeta potential, morphology, stability, molecular interactions, entrapment efficiency, and loading capacity, were investigated. Biocompatibility was assessed via MTT assay on mesenchymal stem cells. For the in vivo study, 24 adult male rats were randomly divided into four groups (n=6): control, ethanol, silymarin + ethanol, and silymarin phytosome + ethanol, and the hepatoprotective effects of the formulation were evaluated.

Results: Silymarin-loaded phytosome nanoparticles with an average size of approximately 100 nm were successfully synthesized and exhibited favorable biocompatibility. Administration of silymarin phytosome significantly reduced ethanol-induced elevation of liver injury markers (ALT, AST, ALP, GGT, and MDA) while simultaneously increasing the activity of the antioxidant enzyme GPx (P<0.05). Histopathological examination further confirmed that the formulation markedly attenuated ethanol-induced tissue damage and structural alterations in the liver.

Conclusion: Silymarin phytosome nanoparticles effectively reduced ethanol-induced liver injury by enhancing bioavailability and potentiating antioxidant and hepatoprotective properties. This formulation represents a novel and promising therapeutic strategy for the prevention and treatment of alcoholic liver disease.

References

Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Rev Dis Primers 2018; 4: 1-22. https://doi.org/10.1038/s41572-018-0021-8

Lamas-Paz A, Hao F, Nelson LJ, Vázquez MT, Canals S, Del Moral MG, et al. Alcoholic liver disease: Utility of animal models. World J Gastroenterol. 2018; 24: 5063. https://doi.org/10.3748/wjg.v24. i45.5063

Bellentani S. The epidemiology of non‐alcoholic fatty liver disease. Liver Int 2017; 37: 81-4. https://doi.org/10.3748/wjg.v24.i45.5063

Walsh K, Alexander G. Alcoholic liver disease. Postgrad Med J 2000; 76: 280-6. https://doi.org/10.1136/pmj.76.895.280

Teschke R. Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects. Biomedicines 2018; 6: 106. https://doi.org/10.3390/ biomedicines6040106

Jiang Y, Zhang T, Kusumanchi P, Han S, Yang Z, Liangpunsakul S. Alcohol metabolizing enzymes, microsomal ethanol oxidizing system, cytochrome P450 2E1, catalase, and aldehyde dehydrogenase in alcohol-associated liver disease. Biomedicines 2020; 8: 50. https://doi.org/10.3390/biomedicines8030050

Dupont I, Lucas D, Clot P, Ménez C, Albano E. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J. Hepatol 1998; 28: 564-71. https://doi.org/10.1016/ S0168-8278(98)80279-1

Cho YE, Mezey E, Hardwick JP, Salem Jr N, Clemens DL, Song BJ. Increased ethanol‐inducible cytochrome P450‐2E1 and cytochrome P450 isoforms in exosomes of alcohol‐exposed rodents and patients with alcoholism through oxidative and endoplasmic reticulum stress. Hepatol. Commun 2017; 1: 675-90. https://doi. org/10.1002/hep4.1066

Ullah U, Badshah H, Malik Z, Uddin Z, Alam M, Sarwar S, et al. Hepatoprotective effects of melatonin and celecoxib against ethanol-induced hepatotoxicity in rats. Immunopharmacol. Immunotoxicol 2020; 42: 255-63. https://doi.org/10.1080/0892397 3.2020.1746802

Elnaggar AS, El-Said EA, Ali R. Physiological and immunological responses of ducks (Cairina moschata domestica) to silymarin supplementation. Egypt Poult Sci J 2021;40:895-913. https://doi. org/10.21608/epsj.2021.177227

El Rabey HA, Rezk SM, Sakran MI, Mohammed GM, Bahattab O, Balgoon MJ, et al. Green coffee methanolic extract and silymarin protect against CCl4-induced hepatotoxicity in albino male rats. BMC Complement Med Ther 2021; 21: 1-11. https://doi. org/10.1186/s12906-020-03186-x

Downloads

Published

2026-09-06

Issue

Vol 21, No 1:2026

Section

Original Article(s)

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Gohari Mahmoudabad, A. . ., Gheybi , F. ., Mehrabi , M. ., Masoudi , A. ., Mobasher , Z. ., Vahedi , H. ., Gharravi , A. M. ., Bitaraf , F. S. ., & Rezayat Sorkhabadi, S. M. . . (2026). Evaluation of the Protective Effect of Silymarin Phytosome Nanoparticles on Ethanol-Induced Diseas e Toxicity in Rats. Knowledge and Health in Basic Medical Sciences, 21(1), Page:29-39. https://doi.org/10.22100/jkh.v21i1.3616

Most read articles by the same author(s)